Investor-grade commercial diligence and transaction support to drive better investment decisions, built for deal timelines, not generic strategy engagements.
"We drive decisions, not just inform them."
An operator-and-banker perspective, applied with the analytical rigor of a strategy consultancy, at the pace a live deal actually demands.
Most engagements fail in the translation from insight to deal execution. We stay engaged across the full lifecycle: one team, no handoff, no lost context.
Comprehensive support across therapeutics, diagnostics, medical devices, and pharma services, spanning the entire product life cycle.
Traditional life sciences strategy work, defining the value proposition and imperatives that set up the next transaction.
Learn more →Hypothesis-driven diligence, buy-side and sell-side, that translates into a clear investment recommendation.
Learn more →Buy-side and sell-side support, converting non-consensus opportunities into high-conviction, actionable transactions.
Learn more →Tell us about your asset, target, or strategic challenge. We'll follow up within one business day.
Start a Conversation →